Literature DB >> 31471411

Surgical Resection of Colorectal Cancer With Distant Metastases to Other than Liver or Lung.

Atsushi Naito1,2, Yoshinori Kagawa3, Kenji Kawai3, Atsushi Takeno3, Yutaka Takeda3, Masahisa Ohtsuka2, Yozo Suzuki2, Mitsunobu Imasato2, Yujiro Fujie2, Hiroyuki Nakaba2, Hiroki Akamatsu2, Kohei Murata3.   

Abstract

BACKGROUND/AIM: If both distant metastases and the primary tumour of colorectal cancer (CRC) are resectable, resection of the distant metastases is considered. The aim of this retrospective study was to determine the efficacy of curative resection of both primary and metastatic lesions in organs other than liver or lung in CRC patients. PATIENTS AND METHODS: The medical records of 23 CRC patients who received R0 resection for primary and metastatic regions between 2009 and 2018 were retrospectively analyzed.
RESULTS: The 3-year overall survival (OS) in all 23 cases was 80.0%. There was no clinicopathological factor associated with OS on univariate analysis.
CONCLUSION: Curative surgical resection appears to be useful for distant CRC metastases to organs other than liver or lung. Copyright
© 2019, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Colorectal cancer; R0 resection; metastases

Year:  2019        PMID: 31471411      PMCID: PMC6755025          DOI: 10.21873/invivo.11643

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  11 in total

Review 1.  Systematic review of prognostic factors related to overall survival in patients with stage IV colorectal cancer and unresectable metastases.

Authors:  Andrew P Stillwell; Yik-Hong Ho; Craig Veitch
Journal:  World J Surg       Date:  2011-03       Impact factor: 3.352

2.  Regional Lymph Nodes Status and Ratio of Metastatic to Examined Lymph Nodes Correlate with Survival in Stage IV Colorectal Cancer.

Authors:  Shahid Ahmed; Anne Leis; Selliah Chandra-Kanthan; Anthony Fields; Adnan Zaidi; Tahir Abbas; Duc Le; Bruce Reeder; Punam Pahwa
Journal:  Ann Surg Oncol       Date:  2016-03-25       Impact factor: 5.344

3.  Long-Term Outcomes After R0 Resection of Synchronous Peritoneal Metastasis from Colorectal Cancer Without Cytoreductive Surgery or Hyperthermic Intraperitoneal Chemotherapy.

Authors:  Dai Shida; Shunsuke Tsukamoto; Hiroki Ochiai; Yukihide Kanemitsu
Journal:  Ann Surg Oncol       Date:  2017-10-23       Impact factor: 5.344

Review 4.  Current management of colorectal liver metastases.

Authors:  L W Martin; R S Warren
Journal:  Surg Oncol Clin N Am       Date:  2000-10       Impact factor: 3.495

5.  Outcome after ovarian/adnexal metastectomy in metastatic colorectal carcinoma.

Authors:  D Rayson; E Bouttell; F Whiston; L Stitt
Journal:  J Surg Oncol       Date:  2000-11       Impact factor: 3.454

6.  FOLFOXIRI plus bevacizumab versus FOLFIRI plus bevacizumab as first-line treatment of patients with metastatic colorectal cancer: updated overall survival and molecular subgroup analyses of the open-label, phase 3 TRIBE study.

Authors:  Chiara Cremolini; Fotios Loupakis; Carlotta Antoniotti; Cristiana Lupi; Elisa Sensi; Sara Lonardi; Silvia Mezi; Gianluca Tomasello; Monica Ronzoni; Alberto Zaniboni; Giuseppe Tonini; Chiara Carlomagno; Giacomo Allegrini; Silvana Chiara; Mauro D'Amico; Cristina Granetto; Marina Cazzaniga; Luca Boni; Gabriella Fontanini; Alfredo Falcone
Journal:  Lancet Oncol       Date:  2015-08-31       Impact factor: 41.316

7.  Ovarian metastasis from colorectal cancer: prognostic value of radical oophorectomy.

Authors:  Francesca Erroi; Marco Scarpa; Imerio Angriman; Attilio Cecchetto; Lara Pasetto; Eleonora Mollica; Marina Bettiol; Cesare Ruffolo; Lino Polese; Umberto Cillo; Davide F D'Amico
Journal:  J Surg Oncol       Date:  2007-08-01       Impact factor: 3.454

8.  Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions.

Authors:  Tomoyuki Kato; Kenzo Yasui; Takashi Hirai; Yukihide Kanemitsu; Takeo Mori; Kenichi Sugihara; Hidetaka Mochizuki; Junji Yamamoto
Journal:  Dis Colon Rectum       Date:  2003-10       Impact factor: 4.585

9.  Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer.

Authors:  Toshiaki Watanabe; Kei Muro; Yoichi Ajioka; Yojiro Hashiguchi; Yoshinori Ito; Yutaka Saito; Tetsuya Hamaguchi; Hideyuki Ishida; Megumi Ishiguro; Soichiro Ishihara; Yukihide Kanemitsu; Hiroshi Kawano; Yusuke Kinugasa; Norihiro Kokudo; Keiko Murofushi; Takako Nakajima; Shiro Oka; Yoshiharu Sakai; Akihito Tsuji; Keisuke Uehara; Hideki Ueno; Kentaro Yamazaki; Masahiro Yoshida; Takayuki Yoshino; Narikazu Boku; Takahiro Fujimori; Michio Itabashi; Nobuo Koinuma; Takayuki Morita; Genichi Nishimura; Yuh Sakata; Yasuhiro Shimada; Keiichi Takahashi; Shinji Tanaka; Osamu Tsuruta; Toshiharu Yamaguchi; Naohiko Yamaguchi; Toshiaki Tanaka; Kenjiro Kotake; Kenichi Sugihara
Journal:  Int J Clin Oncol       Date:  2017-03-27       Impact factor: 3.402

10.  Long-term outcomes after surgical resection in patients with stage IV colorectal cancer: a retrospective study of 129 patients at a single institution.

Authors:  Makoto Sudo; Shinji Furuya; Hiroki Shimizu; Yuuki Nakata; Hiroshi Iino; Kensuke Shiraishi; Hidenori Akaike; Naohiro Hosomura; Yoshihiko Kawaguchi; Hidetake Amemiya; Hiromichi Kawaida; Shingo Inoue; Hiroshi Kono; Daisuke Ichikawa
Journal:  World J Surg Oncol       Date:  2019-03-23       Impact factor: 2.754

View more
  1 in total

1.  Prognostic factors and individualized nomograms predicting overall survival in stage IV rectal cancer patients with different metastatic status: a SEER-based study.

Authors:  Heming Ge; Zhongyi Zhou; Yuqiang Li; Dan Wang; Cenap Güngör
Journal:  Transl Cancer Res       Date:  2022-09       Impact factor: 0.496

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.